Business Combinations - Additional Information (Detail) (USD $)	3 Months Ended					1 Months Ended	3 Months Ended					3 Months Ended
	Dec. 29, 2012	Dec. 24, 2011	Dec. 29, 2012 Property, plant and equipment [Member]	Dec. 29, 2012 Land and buildings [Member]	Jan. 03, 2013 Subsequent Event [Member]	Aug. 01, 2012 Gen-Probe Incorporated [Member]	Dec. 29, 2012 Gen-Probe Incorporated [Member]	Jan. 31, 2013 Gen-Probe Incorporated [Member]	Oct. 31, 2012 Gen-Probe Incorporated [Member]	Dec. 29, 2012 Gen-Probe Incorporated [Member] Minimum [Member]	Dec. 29, 2012 Gen-Probe Incorporated [Member] Maximum [Member]	Dec. 29, 2012 Gen-Probe Incorporated [Member] Developed technology [Member]	Dec. 29, 2012 Gen-Probe Incorporated [Member] Customer contract [Member]	Dec. 29, 2012 Gen-Probe Incorporated [Member] Trade names [Member]
Business Acquisition [Line Items]
Cash paid per share						$ 82.75
Amount paid to shareholders						$ 3,800,000,000
Amount paid to equity award holders						169,000,000
Net debt obtained by the Company to finance the acquisition						3,480,000,000
Direct transaction costs incurred						34,300,000
Remaining fair value of stock options assumed to be recognized as compensation expense							23,200,000
Vesting period							3 years 6 months
Risk free rate	0.50%	0.70%					0.41%
Expected volatility							39.90%
Expected life							3 years 7 months 6 days
Dividend, rate							0.00%
Weighted average fair value of stock options							$ 7.07
Adjustment to valuation of intangibles							2,000,000
Assets held-for-sale							2,200,000
Agreement to sell LIFECODES business to Immucor					85,000,000
Contingent payments of up to an additional amount based on future revenue results					10,000,000
Discount rate used to present value intangible assets and/or contingent consideration										10.00%	12.00%
In-process research and development expense							227,000,000
In-process research and development, value								27,000,000	7,000,000
Total cost of completion of IPR&D projects							51,000,000
Discount rate							12.00%
Finite-lived intangible assets, estimated useful life, years												12 years 6 months	13 years	11 years
Fair value adjustment to increase the carrying amount			$ 107,900,000	$ 70,600,000